If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.
A regimen consisting of rituximab, followed by a continuous infusion of etoposide, vincristine and doxorubicin, given with prednisone and a bolus dose of cyclophosphamide, used for the treatment of aggressive forms of non-Hodgkin’s lymphoma, including mantle cell lymphoma. (NCI Thesaurus)
Related Posts
Recent Posts
